HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A self-adjuvanting anti-tumor nanoliposomal vaccine based on fluorine-substituted MUC1 glycopeptide.

Abstract
Herein, a self-adjuvanting fluorinated MUC1-based nanoliposomal antitumor vaccine was constructed for the first time. Both the tumor-associated antigen and the mode of its presentation affect the immune response for antitumor vaccines.
AuthorsPeijie Dong, Suying Cheng, Yudie Wang, Hang Gao, Yongmin Zhang, Tao Zhu, Peng Yu, Xin Meng
JournalChemical communications (Cambridge, England) (Chem Commun (Camb)) Vol. 58 Issue 62 Pg. 8642-8645 (Aug 02 2022) ISSN: 1364-548X [Electronic] England
PMID35820186 (Publication Type: Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • Cancer Vaccines
  • Glycopeptides
  • Mucin-1
  • Fluorine
Topics
  • Adjuvants, Immunologic (pharmacology)
  • Cancer Vaccines (therapeutic use)
  • Fluorine
  • Glycopeptides
  • Mucin-1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: